Delivery Order SPE2DE24D0013-SPE2D625F1MPR
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $1,190.28 to Cepheid Inc. on August 14, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order does not utilize any set-aside designation and represents a discrete procurement under a broader federal vehicle. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in providing advanced diagnostic systems and test kits for...
- The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,040 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, under contract XPRS4PLEX-10. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, represents a continuation of Cepheid's ongoing provision of diagnostic solutions to federal healthcare systems. The contract carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- The U.S. Defense agency's Medical Supply Chain issued a delivery order valued at $4,901.39 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract number GXCT/NG-10. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid specializes in providing advanced molecular...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The Defense Logistics Agency awarded a delivery order to Cepheid Inc. valued at $26,312.70 under a firm fixed-price contract with an ultimate completion date of August 12, 2025. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. This delivery order carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1MPRDelivery Order
The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number 4569178579. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, serving multiple federal agencies including the Department of Veterans Affairs and Defense Logistics Agency. This delivery order likely draws from one of Cepheid's existing Indefinite Delivery Vehicle contracts with the VA, which provide ongoing procurement authority for molecular diagnostic testing reagents, assays, and related equipment. The company's core offerings include GeneXpert diagnostic systems and associated testing services for conditions such as COVID-19, influenza, respiratory syncytial virus, and other infectious diseases critical to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/20/25 |